Molecular imaging probes for 31P contrast
<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...
第一著者: | Tear, L |
---|---|
その他の著者: | Faulkner, S |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2018
|
主題: |
類似資料
-
Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
著者:: T Mortezazadeh, 等
出版事項: (2020-02-01) -
Magnetic Resonance Imaging Contrast Agents: A Review of Literature
著者:: Zahra Sahraei, 等
出版事項: (2015-10-01) -
Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
著者:: Marco Moscatelli, 等
出版事項: (2023-10-01) -
Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
著者:: Caterina Beatrice Monti, 等
出版事項: (2020-04-01) -
Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
著者:: Simona Bussi, 等
出版事項: (2020-02-01)